Abnormal expression of CD13/CD11b and CD13/CD16 differentiation antigens was observed, and no evidence of abnormal immunophenotype associated with acute leukemia, high−risk MDS, lymphoma, or myeloma was detected. The gene discussed is ANPEP; the disease is plasma cell myeloma.